chr16-1979819-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_172167.3(NOXO1):c.671G>T(p.Arg224Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000105 in 1,565,724 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_172167.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000722 AC: 11AN: 152280Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.0000455 AC: 8AN: 175792Hom.: 0 AF XY: 0.0000420 AC XY: 4AN XY: 95302
GnomAD4 exome AF: 0.000109 AC: 154AN: 1413326Hom.: 0 Cov.: 32 AF XY: 0.000107 AC XY: 75AN XY: 699432
GnomAD4 genome AF: 0.0000722 AC: 11AN: 152398Hom.: 0 Cov.: 34 AF XY: 0.0000805 AC XY: 6AN XY: 74522
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 08, 2024 | The c.686G>T (p.R229L) alteration is located in exon 6 (coding exon 6) of the NOXO1 gene. This alteration results from a G to T substitution at nucleotide position 686, causing the arginine (R) at amino acid position 229 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at